Prothena Corporation plc (0Y3M.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 02:49PM BST. Market open.
| Previous close | 21.10 |
| Open | 21.32 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 21.32 - 21.32 |
| 52-week range | 21.32 - 79.15 |
| Volume | |
| Avg. volume | 345 |
| Market cap | 6.956M |
| Beta (5Y monthly) | 0.24 |
| PE ratio (TTM) | 0.16 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Investor's Business Daily
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
The Alzheimer's treatment space is heating up — and could soon leave Eli Lilly's embattled drug, donanemab, in the dust, experts say.
- Zacks
CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
Per Biogen (BIIB)/Eisai, the delay in CHMP recommendation for lecanemab is entirely related to procedural reasons at the EMA and is not related to the companies' regulatory filing.
- Simply Wall St.
Prothena Full Year 2023 Earnings: Beats Expectations
Prothena ( NASDAQ:PRTA ) Full Year 2023 Results Key Financial Results Revenue: US$91.4m (up 70% from FY 2022). Net...
© 2024 Yahoo. All rights reserved.